These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16382376)

  • 21. Trebenzomine: a new psychotropic agent with potential as an antipsychotic and an antidepressant [proceedings].
    Borgen LA
    Psychopharmacol Bull; 1979 Apr; 15(2):92-4. PubMed ID: 34847
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical trials of new antipsychotics: a critical appraisal.
    Barbui C; Garattini S
    Int Clin Psychopharmacol; 1999 Mar; 14(2):133-7. PubMed ID: 10220130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How long should treatments be continued?
    Craig JC; Webster AC; Loy C
    BMJ; 2010 Aug; 341():c4102. PubMed ID: 20724403
    [No Abstract]   [Full Text] [Related]  

  • 24. [For: is monotherapy the gold standard of psychopharmacology?].
    Fehr C
    Psychiatr Prax; 2006 Jul; 33(5):207-8. PubMed ID: 16802258
    [No Abstract]   [Full Text] [Related]  

  • 25. Sex selection bias in schizophrenia antipsychotic trials.
    Chaves AC; Seeman MV
    J Clin Psychopharmacol; 2006 Oct; 26(5):489-94. PubMed ID: 16974190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical evaluation of cyamemazine].
    Nurowska K
    Psychiatr Pol; 1983; 17(5-6):389-95. PubMed ID: 6142492
    [No Abstract]   [Full Text] [Related]  

  • 27. Duration of risperidone treatment for BPSD.
    Snowdon J; Brodaty H; Ames D; Day S
    Int J Geriatr Psychiatry; 2006 Jul; 21(7):699-701. PubMed ID: 16821255
    [No Abstract]   [Full Text] [Related]  

  • 28. Discontinuing and switching antipsychotic medications: understanding the CATIE schizophrenia trial.
    Weiden PJ
    J Clin Psychiatry; 2007; 68 Suppl 1():12-9. PubMed ID: 17286523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Should the CATIE study be a wake-up call?
    Ragins M
    Psychiatr Serv; 2005 Dec; 56(12):1489. PubMed ID: 16339608
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical trial going on for 10 years - how is it possible?
    Mimica N; Folnegović-Smalc V; Uzun S; Kozumplik O
    Psychiatr Danub; 2009 Sep; 21(3):329. PubMed ID: 19794350
    [No Abstract]   [Full Text] [Related]  

  • 31. The influence of study design on the results of pharmacoepidemiologic studies of diabetes risk with antipsychotic therapy.
    Gianfrancesco F; Wang RH; Nasrallah HA
    Ann Clin Psychiatry; 2006; 18(1):9-17. PubMed ID: 16517448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The roles of efficacy, safety, and tolerability in antipsychotic effectiveness: practical implications of the CATIE schizophrenia trial.
    Nasrallah HA
    J Clin Psychiatry; 2007; 68 Suppl 1():5-11. PubMed ID: 17286522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality of reporting controlled clinical trials on treatment of the acute mania phase of bipolar disorder with new antipsychotic drugs.
    Arbaizar B; Gómez-Acebo I; Llorca J
    Pharmacopsychiatry; 2008 Nov; 41(6):240-1. PubMed ID: 19067261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Against: is monotherapy the gold standard of psychopharmacology?].
    Bechter K
    Psychiatr Prax; 2006 Jul; 33(5):208-10. PubMed ID: 16874937
    [No Abstract]   [Full Text] [Related]  

  • 35. Schizophrenia, Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and number needed to treat: how can CATIE inform clinicians?
    Citrome L; Stroup TS
    Int J Clin Pract; 2006 Aug; 60(8):933-40. PubMed ID: 16893436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Testing the efficacy of new neuroleptic drugs.
    Hirsch SR; Barnes TR
    Psychopharmacol Ser; 1990; 8():26-36. PubMed ID: 1974048
    [No Abstract]   [Full Text] [Related]  

  • 38. [Use of neuroleptics in psychotic states].
    Gayral LF; Escande M
    Rev Prat; 1984 Mar; 34(13):607-17. PubMed ID: 6143387
    [No Abstract]   [Full Text] [Related]  

  • 39. In the aftermath of CATIE: how should administrators value atypical antipsychotic medications?
    Luchins DJ
    Adm Policy Ment Health; 2006 Sep; 33(5):541-3. PubMed ID: 16688482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is the Defined Daily Dose system a reliable tool for standardizing antipsychotic dosages?
    Nosè M; Tansella M; Thornicroft G; Schene A; Becker T; Veronese A; Leese M; Koeter M; Angermeyer M; Barbui C
    Int Clin Psychopharmacol; 2008 Sep; 23(5):287-90. PubMed ID: 18703938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.